Home Cart Sign in  
Chemical Structure| 69408-81-7 Chemical Structure| 69408-81-7

Structure of Amonafide
CAS No.: 69408-81-7

Chemical Structure| 69408-81-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage.

Synonyms: AS1413; Benzisoquinolinedione; Xanafide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Amonafide

CAS No. :69408-81-7
Formula : C16H17N3O2
M.W : 283.33
SMILES Code : O=C(C1=CC(N)=CC2=CC=CC3=C21)N(C3=O)CCN(C)C
Synonyms :
AS1413; Benzisoquinolinedione; Xanafide
MDL No. :MFCD00866438
InChI Key :UPALIKSFLSVKIS-UHFFFAOYSA-N
Pubchem ID :50515

Safety of Amonafide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Amonafide

DNA

Isoform Comparison

Biological Activity

Target
  • Topo II

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00273884 Acute Myeloid Leukemia Phase 2 Completed - -
NCT00074100 Breast Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00087854 Prostate Cancer Phase 1 Phase 2 Completed - United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Maryland Cancer Center at John Hopkins Baltimore, Maryland, United States, 21231 United States, Missouri Barnard Cancer Center St.Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Herbert Irving Cancer Center New York, New York, United States, 10032-3789 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01066494 Acute Myeloid Leukemia Phase 2 Unknown January 2011 Georgia ... More >> Institute of Haematology and Transfusiology Tbilisi, Georgia, 0177 Medulla - Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 Hema - Haematology and Chemotherapy Clinic Tbilisi, Georgia Ukraine Institure of URgent adn Recovery Surgery n.a. V.K. gusaka of Academy Medical Science of Ukraine Donetsk, Ukraine, 83045 Kyiv bone Marrow Transplantation Centre Kiev, Ukraine, 03115 Vinnytsya Regional clinical Hospital Vinnytsya, Ukraine, 21018 Less <<
NCT00715637 Secondary Acute Myeloid Leukem... More >>ia (Secondary AML, sAML) Less << Phase 3 Unknown - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.53mL

0.71mL

0.35mL

17.65mL

3.53mL

1.76mL

35.29mL

7.06mL

3.53mL

References

 

Historical Records

Categories